CitroTech Inc. (CITR) Spending and interest coverage
- R&D / revenue · 12 months: Value 31.69%; Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
- Stock-based compensation / revenue · 12 months: Value 742.88%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
- Interest coverage · 12 months: Value -25.07×; Formula and calculation Operating income ÷ reported interest expense..
Spending and interest coverage
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | 31.69% | Research and development expense / revenue. Period ending 2026-06-30. $427.79K ÷ $1.35M × 100 ≈ 31.69% |
| Stock-based compensation / revenue · 12 months | 742.88% | Share-based compensation / revenue. Period ending 2026-06-30. $10.03M ÷ $1.35M × 100 ≈ 742.88% |
| Interest coverage · 12 months | -25.07× | Operating income ÷ reported interest expense. $-17.96M ÷ $716.43K ≈ -25.07× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | 427.79K USD | Research and Development Expense |
| Revenue | 1.35M USD | |
| Stock-based compensation | 10.03M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | -17.96M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | 716.43K USD | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: Reported. Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $427.79K | $1.35M | $10.03M | $-17.96M | $716.43K | 31.69% | 742.88% | -25.07× | Reported |
| 2026-03-31 | $272.00K | $1.76M | $12.48M | $-17.48M | $1.26M | 15.48% | 710.31% | -13.82× | Reported |
| 2025-12-31 | $198.50K | $2.38M | $19.14M | $-16.50M | $1.51M | 8.34% | 803.73% | -10.92× | Reported |
| 2025-09-30 | (m) | $2.01M | $6.08M | $-11.91M | (m) | (m) | 301.98% | (m) | (m) |
| 2025-06-30 | (m) | $1.83M | $3.76M | $-8.24M | (m) | (m) | 205.07% | (m) | (m) |
| 2025-03-31 | (m) | $1.34M | $2.23M | $-6.13M | (m) | (m) | 166.11% | (m) | (m) |
| 2024-12-31 | $14.00K | $808.37K | $1.86M | $-5.30M | (m) | 1.73% | 230.34% | (m) | (m) |
| 2024-09-30 | (m) | $1.00M | $1.86M | $-4.29M | $96.57K | (m) | 186.07% | -44.40× | Reported |
| 2024-06-30 | (m) | $1.07M | $10.88M | $-12.81M | $4.45K | (m) | 1018.55% | -2875.92× | Reported |
| 2024-03-31 | (m) | $898.07K | $10.58M | $-12.38M | $5.04K | (m) | 1178.31% | -2457.53× | Reported |
| 2023-12-31 | (m) | $520.64K | $8.97M | $-10.10M | $4.33K | (m) | 1722.26% | -2333.16× | Reported |
| 2023-09-30 | (m) | $260.89K | $8.97M | $-9.99M | $2.70K | (m) | 3437.01% | -3702.70× | Reported |
| 2023-06-30 | (m) | $105.21K | $146.85K | $-1.27M | $1.01K | (m) | 139.57% | -1248.16× | Reported |
| 2023-03-31 | (m) | $118.33K | $2.19M | $-3.23M | $430.00 | (m) | 1848.14% | -7509.83× | Reported |
| 2022-12-31 | (m) | $62.73K | $2.10M | $-2.92M | $255.00 | (m) | 3347.57% | -11445.33× | Reported |
| 2022-09-30 | (m) | (m) | $2.10M | $-2.68M | $76.00 | (m) | (m) | -35309.04× | Reported |
| 2022-06-30 | (m) | (m) | $2.10M | $-2.40M | $945.00 | (m) | (m) | -2539.42× | Reported |
| 2022-03-31 | (m) | (m) | (m) | $-61.53K | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | (m) | (m) | $0.00 | $-37.91K | $1.47K | (m) | (m) | -25.81× | Reported |
| 2021-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | (m) | (m) | $100.00K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ASCENT INDUSTRIES CO. (ACNT) | United States | $0.132B | -30.55 |
| Loop Industries, Inc. (LOOP) | $0.023B | -5.50 | |
| GULF RESOURCES, INC. (GURE) | $0.006B | ||
| Ecovyst Inc. (ECVT) | United States | $1.110B | -22.22 |
| FMC CORP (FMC) | United States | $1.201B | -0.52 |
| Huntsman CORP (HUN) | United States | $1.540B | -6.95 |
| OLIN Corp (OLN) | United States | $1.852B | -11.54 |
| Chemours Co (CC) | United States | $2.136B | -10.64 |
| INNOSPEC INC. (IOSP) | United States | $2.380B | 16.37 |
| Ingevity Corp (NGVT) | United States | $2.468B | 47.72 |